Please follow the link to be taken to the Department of Psychiatry’s YouTube channel which will contain current and future presentations by Penn faculty and staff as well as guest speakers. Please note that through the YouTube channel you can subscribe to become aware of any new presentations that are uploaded.
University of Pennsylvania : Psychiatry Seminars
Predicting Smoking Relapse from Working Memory-Related Neural Activity
Unbridled Passions, Imaging the Brain Substrates Relapse Vulnerability
Brief Overview of Medications for OUD
Novel Treatments for Cocaine and Opioid Use Disorder
The Opioid Epidemic in Philadelphia
Using the EHR (electronic health record) data to understand risk for opioid use disorder (OUD Phenotypes
PET technology at Penn: From Early Days to the New Explorer
Polygenic Risk Scores for Substance Use Disorders: Ready for Prime Time?
PET Quantification and Quality Control
Shared Genetic Influences Underlie Alcohol Use Disorder and Schizophrenia
The Neurobiology of Suicide Vulnerability, by Maria A. Oquendo, MD, PhD
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Single Cell Transcriptomics in Schizophrenia Postmortem Brain: Moving Beyond Bulk Lysate
Images of a Pandemic: using PET to understand addiction
Metabolic ketosis as a potential treatment for alcohol use disorders
New Data: Do polygenic risk scores for Opioid Use Disorder (OUD) correlate with mu opioid receptor binding potential, indexed by [11-C] carfentanil binding?
Neuroimaging Pathways to Addiction: Holy Grails and Other Tales
Can molecular imaging help move forward endocannabinoid-focused treatments for psychiatric illness?
Kinetic Modeling in PET: Madness in the Methods or Method to the Madness
Adventures at the intersection of HIV, neuroinflammation and drugs of abuse: new understanding and novel therapeutics
Independent Component Analysis (ICA) of MRI and PET, unmixing addiction in the brain
Discussion of: Auvity, et al. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo
Discussion of: Canchy, et al. - Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction
Directing Bitopic or Bivalent Molecules to Dopamine D3 Receptors for the Treatment of Substance Use Disorders
Psilocybin-assisted psychotherapy to treat alcohol use disorder
Return of the psychedelics: Structure-activity relationship studies of N-benzyl-phenethylamines at the 5-HT2A receptor
Back to Top